Latest news about Anondita Medicare
Anondita Medicare
1,183.35
+94.10(+8.64%)
Company Performance:
View Company Insights1D+8.64%
1M-0.77%
6M+24.19%
1Y+309.11%
5Y+309.11%
More news about Anondita Medicare
03Jun 26
Anondita Medicare targets ₹1,000 Cr revenue in two years
Anondita Medicare Limited reported a 78% YoY increase in FY26 revenue to ₹137.42 Cr and a 107% surge in PAT to ₹34.30 Cr. H2 FY26 revenue grew 83% to ₹83.32 Cr. The company expanded capacity to 806 million units, achieved MDSAP and SABS certifications, and successfully trialed female condoms. Management targets ₹1,000 Cr revenue in two years, driven by export orders from South Africa and Brazil, and new capacity additions.
02Jun 26
Anondita Medicare approves warrant issuance and related party transactions
Anondita Medicare Limited shareholders approved all seven resolutions at the EGM held on May 28, 2026, including the preferential issue of warrants and related party transactions for FY 2026-27. The scrutinizer's report confirmed 100% assent for the resolutions, with promoters abstaining from voting on related party matters.
02Jun 26
Anondita Medicare secures ₹43.14 crore export order from South Africa
Anondita Medicare Limited has secured its first export purchase order worth approximately ₹43.14 crore from Supra Healthcare Johannesburg (Pty) Ltd., South Africa, under the South African Government condom procurement program. The order comprises the supply of male condoms equivalent to 50 containers and is to be executed by September 30, 2026.
30May 26
Anondita Medicare wins Rs 3.92 lakh order from Nepal
Anondita Medicare Limited received a purchase order worth Rs 3,91,902 from Nepal-based S.S.R Traders for supplying condoms, with delivery expected within 4-6 weeks. The order, disclosed under Regulation 30, is not a related party transaction and follows the company's participation in the Nepal Medical Show 2026.
29May 26
Anondita Medicare updates earnings call recording link
Anondita Medicare Limited provided the audio recording link for its earnings conference call held on May 27, 2026, at 4:00 P.M. IST, pursuant to Regulation 30 of SEBI LODR Regulations. The company confirmed no unpublished price sensitive information was shared during the call.
28May 26
Anondita Medicare FY26 PAT jumps 108% to ₹3,429.65 lakh
Anondita Medicare Limited reported a 108% surge in FY26 PAT to ₹3,429.65 lakh, with revenue growing 78% to ₹13,741.57 lakh. EBITDA increased 100% to ₹5,150.85 lakh, supported by margin expansion in H2. The company attributes the growth to capacity enhancement and international expansion under its COBRA brand.
26May 26
Anondita Medicare secures ₹7.18 crore order from CMSS
Anondita Medicare Limited received a ₹7.18 crore purchase order from the Central Medical Services Society for supplying condoms. The order requires a 3% performance security deposit and stipulates delivery in two tranches within 180 days. Payments are due within 60 to 75 days based on sterility test requirements.
26May 26
Anondita Medicare revises warrant valuation report
Anondita Medicare has issued a second corrigendum to its EGM notice regarding the preferential allotment of warrants to promoter Anupam Ghosh. The revision updates the valuation report following a change in the 90 trading day price-band, though the issue price remains fixed at ₹1,038 per warrant. The company also updated the Practicing Company Secretary’s Certificate to reflect the revised valuation details.
12May 26
Anondita Medicare Limited to Participate in Pharma Eurasia 2026 in Uzbekistan
Anondita Medicare Limited has announced its participation in Pharma Eurasia 2026 in Tashkent, Uzbekistan, scheduled from May 20–22, 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015. The company aims to strengthen its presence in Central Asian markets, engage with potential buyers, and showcase its manufacturing capabilities at the physical exhibition.
08May 26
Anondita Medicare Files Newspaper Publication for May 28 EGM Notice
Anondita Medicare Limited filed a Regulation 30 newspaper publication notice confirming its 01/2026-27 EGM advertisements were published on May 7, 2026, in Financial Express and Jansatta. The EGM, scheduled for May 28, 2026, via VC/OAVM, seeks shareholder approval for a preferential warrant issue of ₹29,12,70,000 to promoter Mr. Anupam Ghosh, material RPTs with a subsidiary and the Managing Director, a MOA amendment to include new product categories, and managerial remuneration revisions for key directors.
Industry Peers
Godrej Consumer Products
Dabur India
Colgate Palmolive
Cupid
P&G Hygiene and Health Care
Gillette
Emami
Mamaearth
Bajaj Consumer CareAnondita Medicare
1,061.60
(-0.66%)
434.45
(-1.01%)
2,008.70
(-0.80%)
216.77
(+4.81%)
8,877.00
(-0.33%)
7,831.50
(-0.62%)
420.95
(-1.47%)
474.40
(+0.46%)
590.50
(-10.59%)
1,183.35
(+8.64%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
